Literature DB >> 16391415

Angiotensin II via AT1 receptor accelerates arterial thrombosis in renovascular hypertensive rats.

M Kamińska1, A Mogielnicki, A Stankiewicz, K Kramkowski, T Domaniewski, W Buczko, E Chabielska.   

Abstract

Although there are some in vitro evidence that angiotensin II (Ang II) may promote thrombosis, there is still no data concerning effect of Ang II on arterial thrombus formation. In the present study we have investigated the influence of Ang II on electrically induced arterial thrombosis in a common carotid artery of renovascular hypertensive rats. Furthermore, we examined if Ang II effect is mediated via AT1 receptor. We measured some coagulation and fibrinolytic parameters at the same time. Since platelets play crucial role in the initiation of arterial thrombosis their contribution in the mode of Ang II action was also determined. Intravenous infusion of Ang II caused significant increase in arterial thrombus weight, which was reversed by losartan, selective AT1 receptor antagonist. The prothrombotic effect of Ang II was accompanied by increase in haemostatic and decrease in fibrinolytic potential of rat plasma. While number of data has clearly demonstrated that Ang II can augment human platelets aggregation, at least in rats, platelets were not involved in the mechanism of Ang II action. Our study shows that Ang II via AT1 receptor accelerates arterial thrombosis in renovascular hypertensive rat, therefore may be considered as a risk factor of myocardial infarction or stroke.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16391415

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  14 in total

1.  Angiotensin II-mediated microvascular thrombosis.

Authors:  Elena Y Senchenkova; Janice Russell; Lidiana D Almeida-Paula; Joseph W Harding; D Neil Granger
Journal:  Hypertension       Date:  2010-10-25       Impact factor: 10.190

2.  Elevated blood pressure aggravates intracerebral hemorrhage-induced brain injury.

Authors:  Yan-Hua Sang; Huan-Xing Su; Wu-Tian Wu; Kwok-Fai So; Raymond Tak-Fai Cheung
Journal:  J Neurotrauma       Date:  2011-10-11       Impact factor: 5.269

Review 3.  Acute hypertensive response in patients with intracerebral hemorrhage pathophysiology and treatment.

Authors:  Adnan I Qureshi; Mushtaq H Qureshi
Journal:  J Cereb Blood Flow Metab       Date:  2017-08-16       Impact factor: 6.200

4.  Role of T lymphocytes in angiotensin II-mediated microvascular thrombosis.

Authors:  Elena Y Senchenkova; Janice Russell; Elvira Kurmaeva; Dmitry Ostanin; D Neil Granger
Journal:  Hypertension       Date:  2011-09-12       Impact factor: 10.190

5.  Accelerated rejection, thrombosis, and graft failure with angiotensin II type 1 receptor antibodies.

Authors:  Meghan H Pearl; Richard K Leuchter; Elaine F Reed; Qiuheng Zhang; Robert B Ettenger; Eileen W Tsai
Journal:  Pediatr Nephrol       Date:  2015-05-09       Impact factor: 3.714

6.  Roles of Coagulation and fibrinolysis in angiotensin II-enhanced microvascular thrombosis.

Authors:  Elena Y Senchenkova; Janice Russell; Charles T Esmon; D Neil Granger
Journal:  Microcirculation       Date:  2014-07       Impact factor: 2.628

7.  ACE2-Ang-(1-7)-Mas Axis in Brain: A Potential Target for Prevention and Treatment of Ischemic Stroke.

Authors:  Teng Jiang; Li Gao; Jie Lu; Ying-Dong Zhang
Journal:  Curr Neuropharmacol       Date:  2013-03       Impact factor: 7.363

8.  Protective Role of the ACE2/Ang-(1-9) Axis in Cardiovascular Remodeling.

Authors:  María Paz Ocaranza; Jorge E Jalil
Journal:  Int J Hypertens       Date:  2012-01-19       Impact factor: 2.420

9.  Nonclinical evaluation of novel cationically modified polysaccharide antidotes for unfractionated heparin.

Authors:  Bartlomiej Kalaska; Kamil Kaminski; Emilia Sokolowska; Dominik Czaplicki; Monika Kujdowicz; Krystyna Stalinska; Joanna Bereta; Krzysztof Szczubialka; Dariusz Pawlak; Maria Nowakowska; Andrzej Mogielnicki
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

Review 10.  Thromboplasminflammation in COVID-19 Coagulopathy: Three Viewpoints for Diagnostic and Therapeutic Strategies.

Authors:  Satoshi Gando; Takeshi Wada
Journal:  Front Immunol       Date:  2021-06-11       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.